NS-HGlio— 510(k) K221738

Substantially Equivalent

Neosoma, Inc.

FDA 510(k) clearance K221738 for NS-HGlio, Substantially Equivalent on 2022-09-27. Applicant: Neosoma, Inc..

Clearance details

Applicant: Neosoma, Inc.
Product code: Code QIH
Advisory panel: Radiology
Date received: 2022-06-15
Decision date: 2022-09-27
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Groton, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.